CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
MyBiotics is developing a novel probiotic technology that enables the efficient delivery and colonization of beneficial gut bacteria. This innovation allows for the creation of personalized probiotics tailored to individual health needs, addressing various chronic conditions and promoting overall well-being.
Gut-microbiome is an essential part of human health.
Gut bacteria imbalance is now recognized as a crucial factor in the development of many diseases – chronic, obesity, diabetes, liver, cardio, cancer and neurodegenerative.
Traditional probiotics used today, aimed at restoring this imbalance, are not effective:
They are incapable of delivering sufficient number and variety of bacteria to the correct location in the gut and have them colonize.
MyBiotics, a microbiome company, developed a novel…
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
Guests see up to 5 keywords.
